Precision Biosciences
Precision BioSciences is a publicly-traded ($DTIL), clinical stage, advanced gene editing company developing in vivo therapies that incorporate our proprietary, therapeutic grade gene editing technology, ARCUS.
)
January 11-14, 2027 | San Francisco
January 11-14, 2027 | San Francisco
)
)
January 11-14, 2027 | San Francisco
){kind=logo}
){kind=logo}
)